Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Allory · SciRah

Researcher profile · Semantic Scholar

Y. Allory

Share profile

Y. Allory — researcher profile on SciRah

h-index: 59
Works: 350
Citations: 12K

Most-cited papers

Progenitors from the central nervous system drive neurogenesis in cancer
P. Mauffrey, N. Tchitchek, V. Barroca, A. Bemelmans +4 more
2019Nature306 citations
Semantic Scholar
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Patho
C. Pfister, G. Gravis, A. Flechon, M. Soulie +7 more
2020European Urology216 citations Open access
Semantic Scholar
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial
C. Pfister, G. Gravis, A. Flechon, C. Chevreau +8 more
2022Journal of Clinical Oncology163 citations
Semantic Scholar
Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy.
Clarice S. Groeneveld, J. Fontugne, Luc Cabel, I. Bernard-Pierrot +3 more
2021European Journal of Cancer143 citations
Semantic Scholar
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†.
B. V. van Rhijn, L. Mertens, R. Mayr, P. Bostrom +30 more
2020European Urology82 citations
Semantic Scholar
Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer
E. Borcoman, P. De La Rochere, W. Richer, S. Vacher +12 more
2019Oncoimmunology80 citations Open access
Semantic Scholar
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
F. Claps, M. van de Kamp, R. Mayr, P. Bostrom +28 more
2023BJU International66 citations Open access
Semantic Scholar
Escherichia coli-specific CXCL13-producing TFH are associated with clinical efficacy of neoadjuvant PD-1 blockade against muscle-invasive bladder cancer.
A. Goubet, Leonardo Lordello, Carolina Alves Costa Silva, I. Peguillet +57 more
2022Cancer Discovery63 citations Open access
Semantic Scholar
Recurrent activating mutations of PPARγ associated with luminal bladder tumors
N. Rochel, C. Krucker, L. Coutos-Thévenot, J. Ősz +23 more
2019Nature Communications63 citations Open access
Semantic Scholar
Risk factors associated with positive surgical margins’ location at radical cystectomy and their impact on bladder cancer survival
F. Claps, M. van de Kamp, R. Mayr, P. Bostrom +17 more
2021World journal of urology45 citations Open access
Semantic Scholar
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review
Y. Soorojebally, Y. Neuzillet, M. Roumiguié, P. Lamy +10 more
2023World journal of urology41 citations
Semantic Scholar
Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes
S. Koutros, M. Kogevinas, M. Friesen, P. Stewart +22 more
2019Environment International41 citations Open access
Semantic Scholar
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients.
L. Mertens, F. Claps, R. Mayr, P. Bostrom +31 more
2021Urologic oncology39 citations Open access
Semantic Scholar
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
V. Weyerer, Rebecca Weisser, E. Moskalev, F. Haller +13 more
2019Histopathology38 citations Open access
Semantic Scholar
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
M. Rouanne, J. Adam, C. Radulescu, D. Letourneur +25 more
2022Journal of Clinical Investigation36 citations Open access
Semantic Scholar
TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
F. Dufour, L. Silina, Hélène Neyret-Kahn, A. Moreno-Vega +12 more
2019British Journal of Cancer30 citations Open access
Semantic Scholar
Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype
V. Weyerer, M. Eckstein, E. Compérat, H. Juette +7 more
2020Cancers29 citations Open access
Semantic Scholar
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer.
M. Rouanne, R. Betari, C. Radulescu, A. Goubar +6 more
2019European Journal of Cancer29 citations Open access
Semantic Scholar
High Positive Correlations between ANRIL and p16-CDKN2A/p15-CDKN2B/p14-ARF Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an ANRIL–ARF Bidirectional Promoter
K. Drak Alsibai, S. Vacher, D. Meseure, A. Nicolas +11 more
2019Non-Coding RNA28 citations Open access
Semantic Scholar
Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand in FGFR3-mutated Tumors.
Clarice S. Groeneveld, Virginia Sanchez-Quiles, F. Dufour, Mingjun Shi +18 more
2023European Urology27 citations Open access
Semantic Scholar
Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee
A. Masson-Lecomte, V. Vaillant, M. Roumiguié, S. Levy +16 more
2022Cancers26 citations Open access
Semantic Scholar
PD-L1 testing in urothelial bladder cancer: essentials of clinical practice
M. Rouanne, C. Radulescu, J. Adam, Y. Allory
2020World journal of urology24 citations
Semantic Scholar
Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group.
M. Sroussi, R. Elaidi, A. Flechon, M. Lorcet +27 more
2019Clinical Genitourinary Cancer24 citations
Semantic Scholar
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial
T. Lebret, X. Paoletti, G. Pignot, M. Roumiguié +19 more
2023World journal of urology23 citations Open access
Semantic Scholar
FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias.
Ming-Jun Shi, J. Fontugne, A. Moreno-Vega, Xiang-Yu Meng +20 more
2022European Urology23 citations Open access
Semantic Scholar
French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC).
Y. Neuzillet, B. Pradère, E. Xylinas, Y. Allory +8 more
2022Progrès en urologie (Paris)23 citations
Semantic Scholar
Combined MEK and PI3K/p110b inhibition as a novel targeted therapy for malignant mesothelioma displaying sarcomatoid features.
M. Marqués, Robin Tranchant, Blanca Risa-Ebrí, M. L. Suárez-Solís +14 more
2020Cancer Research22 citations Open access
Semantic Scholar
Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24).
C. Thibault, A. Flechon, L. Albiges, C. Joly +15 more
2023European Journal of Cancer21 citations Open access
Semantic Scholar
Multilayer spectrum of intratumoral heterogeneity in basal bladder cancer
N. Sirab, D. Drubay, P. Maillé, T. Popova +14 more
2021Journal of Pathology20 citations
Semantic Scholar
Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
Hélène Neyret-Kahn, J. Fontugne, Xiang-Yu Meng, Clarice S. Groeneveld +17 more
2023Oncogene19 citations Open access
Semantic Scholar
Progression‐associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis
J. Fontugne, J. Wong, Luc Cabel, Hélène Neyret-Kahn +10 more
2023Journal of Pathology19 citations Open access
Semantic Scholar
Recurrent activating mutations of PPAR gamma associated with luminal bladder tumors.
N. Rochel, C. Krucker, L. Coutos-Thévenot, J. Ősz +23 more
201919 citations
Semantic Scholar
Tumeurs germinales du testicule : caractéristiques histopathologiques et moléculaires
Morgan Tourne, C. Radulescu, Y. Allory
2019Bulletin du Cancer19 citations Open access
Semantic Scholar
Reference-free transcriptome exploration reveals novel RNAs for prostate cancer diagnosis
M. Pinskaya, Z. Saci, M. Gallopin, M. Gabriel +10 more
2019Life Science Alliance18 citations Open access
Semantic Scholar
Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort
F. Kullmann, P. Strissel, R. Strick, R. Stoehr +23 more
2021Journal of Clinical Pathology17 citations Open access
Semantic Scholar
Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
C. Le Goux, S. Vacher, A. Schnitzler, Nicolas Barry Delongchamps +7 more
2020Scientific Reports17 citations Open access
Semantic Scholar
Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer
S. Vacher, Voreak Suybeng, E. Girard, J. Masliah-Planchon +11 more
2020Cancers16 citations Open access
Semantic Scholar
MSH3: a confirmed predisposing gene for adenomatous polyposis
M. Villy, J. Masliah-Planchon, A. Schnitzler, Hélène Delhomelle +21 more
2023Journal of Medical Genetics15 citations
Semantic Scholar
PLEKHS1: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer
G. Pignot, C. Le Goux, S. Vacher, A. Schnitzler +8 more
2019Oncology Letters15 citations Open access
Semantic Scholar
Overexpression of Nucleolin and Associated Genes in Prostate Cancer
V. Firlej, P. Soyeux, M. Nourieh, E. Huet +6 more
2022International Journal of Molecular Sciences14 citations Open access
Semantic Scholar
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UC.
Myriam Kossaï, C. Radulescu, J. Adam, Anaïs Dziegielewski +5 more
2021Urologic oncology14 citations Open access
Semantic Scholar
RNA-seq profiling of upper tract urothelial carcinoma: bladder cancer consensus classification relevance, molecular heterogeneity and differential immune signatures.
J. Fontugne, E. Xylinas, C. Krucker, Victoria Dixon +10 more
2023Modern Pathology13 citations
Semantic Scholar
Randomized phase III trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as perioperative chemotherapy for muscle invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathol
S. Culine, G. Gravis, A. Flechon, M. Soulie +7 more
2020Journal of Clinical Oncology13 citations
Semantic Scholar
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial
S. Culine, V. Harter, C. Krucker, G. Gravis +9 more
2023Cancers12 citations Open access
Semantic Scholar
The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer
Charly Blanc, A. Moktefi, A. Jolly, P. de la Grange +15 more
2022British Journal of Cancer12 citations Open access
Semantic Scholar
Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer
T. Muilwijk, M. Akand, F. Van der Aa, V. de Coninck +7 more
2021Journal of Cellular and Molecular Medicine12 citations Open access
Semantic Scholar
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies
H. Lang, C. Beraud, Luc Cabel, J. Fontugne +21 more
2022bioRxiv11 citations Open access
Semantic Scholar
French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC).
Y. Neuzillet, F. Audenet, Y. Loriot, Y. Allory +8 more
2022Progrès en urologie (Paris)11 citations
Semantic Scholar
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
S. Culine, V. Harter, G. Gravis, A. Flechon +27 more
2021Clinical Genitourinary Cancer11 citations Open access
Semantic Scholar
Rational testing for gene fusion in colorectal cancer: MSI and RAS-BRAF wild-type metastatic colorectal cancer as target population for systematic screening.
M. Delaye, S. Ibadioune, C. Julié, C. Marin +13 more
2022European Journal of Cancer9 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Radvanyi×16
Invite
F. Radvanyi — researcher profile on SciRah
Y. Neuzillet×13
Invite
Y. Neuzillet — researcher profile on SciRah
C. Krucker×10
Invite
C. Krucker — researcher profile on SciRah
I. Bièche×10
Invite
I. Bièche — researcher profile on SciRah

×10

Invite

T. Lebret — researcher profile on SciRah

I. Bernard-Pierrot×9

Invite

I. Bernard-Pierrot — researcher profile on SciRah

Invite

G. Gravis — researcher profile on SciRah

A. de Reyniès×8

Invite

A. de Reyniès — researcher profile on SciRah

Invite

M. Eckstein — researcher profile on SciRah

Invite

S. Vacher — researcher profile on SciRah

C. Radulescu×8

Invite

C. Radulescu — researcher profile on SciRah

Invite

A. Flechon — researcher profile on SciRah